Medicated Skin Care was One of the Strongest Performers in the UK's OTC Healthcare Market.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c43900) has announced the addition of Medicated Skin Care in the United Kingdom to their offering

Our Medicated Skin Care in UK report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

- Get a detailed picture of the medicated skin care industry

- Identify factors driving change

- Understand the competitive environment, the market's major players and leading brands

- Use five-year forecasts to assess how the market is predicted to develop

With a network of over 600 analysts worldwide, we have the unique capability to develop reliable information resources to help drive informed strategic planning.

Topics Covered

1. EXECUTIVE SUMMARY

2. OPERATING ENVIRONMENT

- 2.1 OTC Registration and Classification

- 2.2 Vitamins and Dietary Supplements Registration and Classification

- 2.3 Advertising

- 2.4 Packaging and Labelling

- 2.5 Distribution

- 2.6 De-listing or De-reimbursement

- 2.7 Traditional Remedies

- 2.8 Homoeopathy

- 2.9 Generics

- 2.10 Consumer Expenditure on Health Goods and Medical Services

- 2.11 Life Expectancy

3. OTC HEALTHCARE SALES

- 3.1 Market Performance

- 3.2 Switches

- 3.3 Key Trends and Developments

- 3.4 Competitive Environment

- 3.5 Leading Company Profile: Bayer Plc

- 3.6 Leading Company Profile: Boots Healthcare International

- 3.7 Leading Company Profile: GlaxoSmithKline Plc

- 3.8 Leading Company Profile: Johnson & Johnson MSD Ltd

- 3.9 Leading Company Profile: Novartis Pharmaceuticals UK Ltd

- 3.10 Leading Company Profile: Pfizer Consumer Healthcare Ltd

- 3.11 Leading Company Profile: Reckitt Benckiser Plc

- 3.12 Leading Company Profile: Roche Products Ltd

- 3.13 Leading Company Profile: Seven Seas Ltd

- 3.14 Leading Company Profile: SSL International Plc

- 3.15 Leading Company Profile: Wyeth Consumer Healthcare

- 3.16 Emerging and Niche Companies

- 3.17 Retail Distribution

- 3.18 Retailer Activity and Private Label Trends

- 3.19 Forecast Market Performance

4. MEDICATED SKIN CARE SALES

- 4.1 Sector Performance

- 4.2 New Product Developments

- 4.3 Medicated Skin Care by Herbal/Standard Split

- 4.4 Acne Treatments Brand Shares

- 4.5 Hair Loss Treatments Brand Shares

5. DEFINITIONS

Summary

Key drivers of growth

On a brighter note, dietary supplements, along with medicated skin care and smoking cessation, represented the strongest performers within OTC healthcare in 2005, with growth in current value terms of around 6% over 2004. In each case, greater consumer awareness of issues concerning health and wellness supported sales. In dietary supplements, for example, media coverage espousing the virtues of fish oils helped develop the sector. Other sectors also did their bit to increase market sales in 2005, with the recent emergence of OTC statins, in particular Johnson & Johnson's Zocor Heart-Pro launched in May 2004, helping to develop a new facet to the market.

Companies Mentioned Include:

- GlaxoSmithKline Plc - Crookes Healthcare Ltd - Reckitt Benckiser Plc - Pfizer Consumer Healthcare Ltd - Seven Seas Ltd - SSL International Plc - Boots Co Plc, The - Roche Products Ltd - Wyeth Consumer Healthcare Inc - Ernest Jackson Ltd - Novartis Pharmaceuticals UK Ltd - Bayer Plc - Johnson & Johnson MSD - Holland & Barrett Retail Ltd - Johnson & Johnson Ltd - Masterfoods UK Ltd - Pharmacia & Upjohn Cambridge Ltd - DDD Group, The - Mentholatum Co Ltd, The - Beiersdorf UK Ltd - Chemist Brokers Ltd - Vitabiotics Ltd - Chefaro Proprietaries Ltd - Ransom Consumer Healthcare - Omega Pharma SA - Healthspan Group Ltd - Schering-Plough Ltd - De Witt & Co Ltd, E C - Schering Healthcare Ltd - Procter & Gamble Ltd - Adams Confectionery - Mars UK Ltd - Peter Black Healthcare Ltd

For more information visit http://www.researchandmarkets.com/reports/c43900